In the article on the PTGS2 -765G>C polymorphism and risk of colorectal adenoma in the March 2005 issue (1), the Taqman probes for the PTGS2 -765G>C polymorphism were mislabeled erroneously. The correct probe sequences and fluorescent labels are as follows.

Wild-type (G) allele: 5′6FAM-TTTACCTTTCCCGCCTCTCT-3′MGBNFQ

Variant (C) allele: 5′VIC-TTTACCTTTCCCCCCTCTCT'-3′MGBNFQ

1
Ulrich CM, Whitton J, Yu J-H, et al. PTGS2 (COX-2) -765G>C promoter variant reduces risk of colorectal adenoma among non-users of NSAIDs.
Cancer Epidemiol Biomarkers Prev
2005
;
14
:
616
–9.